Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-21-000015
Filing Date
2021-01-05
Accepted
2021-01-05 08:55:50
Documents
1
Group Members
GRUNDSTEIN

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A OTLK 1.05.21 otlk0121.txt SC 13G/A 13599
  Complete submission text file 0001535610-21-000015.txt   15252
Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-89495 | Film No.: 21504051
SIC: 2836 Biological Products, (No Diagnostic Substances)